Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04371900 · ClinicalTrials.gov registry record · NA
Michigan Contraceptive Access, Research, and Evaluation Study Children: Phase 1
A NA study of Pregnancy, sponsored by University of Michigan.
- Recruiting
- Registry status
- NA
- Development phase
- 4,700
- Enrollment target
- 9
- Study locations
NCT04371900: Recruiting NA study of Pregnancy, sponsored by University of Michigan.
NCT04371900 is a NA study of Pregnancy that is actively recruiting participants, run by University of Michigan. The registered enrollment target is 4,700 participants, above the 848-participant average among 191 other Pregnancy trials with a reported enrollment target (454% higher). The trial reports 9 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04371900, a NA study of Pregnancy, is actively recruiting participants, sponsored by University of Michigan.
- RECRUITING
- Registry status
- NA
- Development phase
- 4,700 participants
- Enrollment target
- 9
- Study locations
Study Summary
This project builds on the Michigan Contraceptive Access Research and Evaluation Study (M-CARES) to evaluate the long-term effects of mothers' access to free contraceptives and reductions in unintended pregnancies on their children's well-being.
Primary Outcome
Number of children born to individual's mother as determined in mother's survey responses and Vital Records (count: 0, 1, 2....)
Conditions Studied
Interventions
- BEHAVIORAL Mother receives voucher valued at 100% of cost of name-brand IUD (March 4, 2019-March 31, 2023)
- BEHAVIORAL Mother receives voucher valued at 50% of cost of name-brand IUD (August 26, 2018-March 3, 2019)
Study Locations (9)
Michigan
- Planned Parenthood - Ann Arbor-West - Ann Arbor
- Planned Parenthood - Detroit - Detroit
- Planned Parenthood - Ferndale - Ferndale
- Planned Parenthood - Grand Rapids - Grand Rapids
- Planned Parenthood - Kalamazoo - Kalamazoo
- Planned Parenthood - Lansing - Lansing
- Planned Parenthood - Livonia - Livonia
- Planned Parenthood - Traverse City - Traverse City
- Planned Parenthood - Warren - Warren
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,700 participants |
| Start Date | 2018-08-26 |
| Est. Completion | 2049-12-31 |
| Phase | NA |
What NCT04371900 shows while recruiting
NCT04371900 is an interventional study that assigns participants to a tested intervention. Its 4,700 participants enrollment target places it among the larger protocols in the corpus, above the 848-participant average among 191 other Pregnancy trials with a reported enrollment target (454% higher).
The record links to 1 condition, with Pregnancy appearing as the primary indexed condition, and to 2 interventions - of which Mother receives voucher valued at 100% of cost of name-brand IUD (March 4, 2019-March 31, 2023) is the first listed.
NCT04371900 lists 9 locations in 1 state (Michigan).
Frequently Asked Questions
What is clinical trial NCT04371900 about?
NCT04371900 is a clinical study titled "Michigan Contraceptive Access, Research, and Evaluation Study Children: Phase 1". This project builds on the Michigan Contraceptive Access Research and Evaluation Study (M-CARES) to evaluate the long-term effects of mothers' access to free contraceptives and reductions in unintended pregnancies on their children's well-being.
What is the current status of trial NCT04371900?
This trial is currently recruiting. It is a NA study. The enrollment target is 4,700 participants. The study started on 2018-08-26. Estimated completion is 2049-12-31.
What conditions does trial NCT04371900 study?
This clinical trial studies the following conditions: Pregnancy.
What interventions are being tested in trial NCT04371900?
The interventions under investigation include: Mother receives voucher valued at 100% of cost of name-brand IUD (March 4, 2019-March 31, 2023) (BEHAVIORAL), Mother receives voucher valued at 50% of cost of name-brand IUD (August 26, 2018-March 3, 2019) (BEHAVIORAL).
Who is sponsoring clinical trial NCT04371900?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04371900 being conducted?
This trial has 9 study locations across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pregnancy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04371900's enrollment target sits among peer trials
4,700 6th of 191 higher than 186 of 191 other Pregnancy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pregnancy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
CGM Adherence Compared to Finger-stick Glucose Monitoring in Pregnancies With Type 2 Pregestational Diabetes
RECRUITING · NA
-
Cocooned Moms Study
RECRUITING · NA
-
CGM for Management of Type 2 Diabetes in Pregnancy
RECRUITING · NA
-
Feasibility of an ADAPTive Intervention to Improve Food Security and Maternal-Child Health
RECRUITING · NA
-
Enhancing Care & Outcomes for Patients During the First Postpartum Year
RECRUITING · NA
-
Mitigating Response to Stressors in Pregnant Women
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05486572 · 4,700 participants · NA
Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI
- NCT06888388 · 4,700 participants
Long-term Safety of Nipple Sparing Mastectomy in Women With High Penetrance Breast Cancer Susceptibility Genes in Breast Cancer
- NCT06535139 · 4,630 participants · NA
ReMARK: Addressing Disparities in Rural HPV-related Cancer Prevention
- NCT01719055 · 4,800 participants
RELIEF - A Global Prospective Observational Post-Market Study to Evaluate Long-Term Effectiveness of Neurostimulation Therapy for Pain
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI